James L. Young

Consumer Services

Health Technology

Profile

James L.
Young has been Vice President of Research and Development Operations for Covidien Ltd.
since June 30, 2008.
He was Vice President of Product Development for Xanodyne Pharmaceuticals, Inc. Dr. Young served in management; strategic development, sales and scientific roles for Nexeon, LLC, AstraZeneca LP and Merck & Co., Inc. He brings 20 years of experience in the pharmaceutical industry.
Dr. Young received a Bachelor's degree in Genetic Biology from Purdue University and a PhD in Molecular Genetics from Ohio State University.

Former positions of James L. Young

Companies	Position	End
Covidien Unlimited Co. Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland.	Chief Tech/Sci/R&D Officer	-

See the detail of James L. Young's experience

Training of James L. Young

Purdue University	Undergraduate Degree
The Ohio State University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies